EP2986623
19-nor-C3,3-tvísetnir C21-N-pýrasólýlsterar og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.4.2014EP published:
7.11.2018EP application number:
14785712.2
EP translation filed:
4.2.2019Grant published:
15.2.2019EPO information:
European Patent Register
Max expiry date:
16.4.2034Expiry date:
16.4.2026Next due date:
30.4.2026
Title:
19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF
Timeline
Today
17.4.2014EP application
7.11.2018EP Publication
4.2.2019Translation submitted
15.2.2019Registration published
16.4.2026Expires
Owner
Name:
Sage Therapeutics, LLCAddress:
9715 Key West Avenue, 20850, Rockville, MD, US
Inventor
Name:
BOTELLA, Gabriel MartinezAddress:
Wayland, Massachusetts, US
Name:
HARRISON, Boyd L.Address:
Princeton Junction, New Jersey, US
Name:
ROBICHAUD, Albert JeanAddress:
Ringoes, New Jersey, US
Name:
SALITURO, Francesco G.Address:
Marlborough, Massachusetts, US
Name:
BERESIS, Richard ThomasAddress:
Shanghai, CN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/CN2013/074323Date:
17.4.2013Country:
WO
Supplementary protection
SPC number:
SPC542
Classification
Categories:
C07J 43/00, C07J 3/00, C07J 7/00, C07J 15/00, A61K 31/57, A61K 31/573, A61K 31/58, A61P 25/00, C07J 1/00, C07J 13/00, C07J 21/00, C07J 31/00, C07J 5/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 2.4.2019
Expires: 16.4.2020
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 20.4.2020
Expires: 16.4.2021
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 26.4.2021
Expires: 16.4.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 10.3.2022
Expires: 16.4.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.3.2023
Expires: 16.4.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.3.2024
Expires: 16.4.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 18.3.2025
Expires: 16.4.2026
Payer: Árnason Faktor ehf.